Cardinal Health, a leading pharmaceutical distributor, is strengthening its presence in specialty medicine through two strategic acquisitions: GI Alliance (GIA) and Advanced Diabetes Supply Group (ADSG). The deals, worth a combined $3.9 billion, are poised to enhance Cardinal Health’s revenue and segment profit growth.

Transaction Details

1. GI Alliance (GIA):

. Cardinal Health will acquire a 71% stake in GIA for $2.8 billion in cash.

. GIA, a gastroenterology-focused management services organization (MSO), operates across 20 states with over 900 physicians in 345 locations.

. The acquisition will position GIA as a platform under Cardinal Health’s Pharmaceutical and Specialty Solutions segment.

2. Advanced Diabetes Supply Group (ADSG):

. Cardinal Health will purchase ADSG for $1.1 billion in cash.

. ADSG, a leader in diabetic medical supplies, serves approximately 500,000 patients annually through its at-home care solutions.

. It will merge with Cardinal Health’s at-home Solutions business.

Both transactions are expected to positively impact non-GAAP earnings per share (EPS) within 12 months of closing and will be reflected in the company’s FY2025 guidance.

Broader Impact

. GIA’s multispecialty platform supports a continuum of care in gastroenterology and complementary fields such as anesthesiology, pathology, and radiology.

. ADSG enhances at-home patient care with innovative diabetes therapies, underscoring Cardinal Health’s commitment to personalized healthcare solutions.

Industry Context

These deals align with Cardinal Health’s recent acquisition activity, including the planned $1.1 billion purchase of Integrated Oncology Network (ION), a community-based oncology platform. Collectively, these moves underscore the company’s strategy to support independent healthcare providers while expanding its specialty care footprint.

CEO Perspective

“Today is an exciting day at Cardinal Health as we announce two strategic and financially compelling transactions that build upon our progress in Specialty and accelerate growth in our at-Home Solutions business,” said CEO Jason M. Hollar. “These acquisitions advance our mission to deliver greater value for providers and patients while driving sustainable shareholder value creation.”